(Q35112433)

6 August 2017

1 reference

title

When to start and when to stop primary prophylaxis in patients with severe haemophilia (English)

1 reference

6 August 2017

0 references

J. Astermark

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12709035

26 December 2023

language of work or name

1 reference

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1365-2516.9.s1.1.x

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1365-2516.9.s1.1.x

26 December 2023

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

26 December 2023

1 reference

6 August 2017

volume

9 Suppl 1

1 reference

6 August 2017

page(s)

32-6; discussion 37

1 reference

Progress in haemophilic care: ethical issues

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Prophylaxis in developed and in emerging countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

The impact of prophyactic treatment on children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Haemophilia prophylaxis in young patients--a long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

When should prophylactic treatment in patients with haemophilia A and B start?--The German experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

The orthopaedic status of severe haemophiliacs in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Milder clinical presentation of haemophilia A with severe deficiency of factor VIII as measured by one-stage assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Modifier genes in haemophilia: their expansion in the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Primary prophylaxis in severe haemophilia should be started at an early age but can be individualized

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Long-term outcome of individualized prophylactic treatment of children with severe haemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

The effects of postponing prophylactic treatment on long-term outcome in patients with severe hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Discontinuation of prophylactic therapy in severe haemophilia: incidence and effects on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Types of bleeding seen during the first 30 months of life in children with severe haemophilia A and B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Port-A-Cath usage in children with haemophilia: experience of 53 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Complications of central venous catheters in patients with haemophilia and inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2516.9.S1.1.X

Modern treatment of haemophilia

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B.

26 December 2023

3

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

Prophylaxis with Factor Concentrates in Preventing Hemophilic Arthropathy

26 December 2023

6

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

A longitudinal study of orthopaedic outcomes for severe factor-VIII-deficient haemophiliacs. The Orthopaedic Outcome Study Group

26 December 2023

7

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

Results of secondary prophylaxis in children with severe hemophilia

26 December 2023

8

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

When are children diagnosed as having severe haemophilia and when do they start to bleed? A 10-year single-centre PUP study

26 December 2023

11

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

Effects of prophylactic treatment regimens in children with severe haemophilia: a comparison of different strategies.

26 December 2023

22

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

Diagnostic symptoms of severe and moderate haemophilia A and B. A survey of 140 cases

26 December 2023

29

1 reference

https://api.crossref.org/works/10.1046/J.1365-2516.9.S1.1.X

26 December 2023

Identifiers

1 reference

6 August 2017

1 reference